FAA1 Agonist-1

Catalog No. :
ACDPQY294
CAS No. :
2102196-57-4
Molecular Formula :
C21H17ClO5S
Molecular Weight :
416.88

IUPAC Name:2-((4-((2'-chloro-[1,1'-biphenyl]-3-yl)methoxy)phenyl)sulfonyl)acetic acid

FAA1 Agonist-1 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$82.00Login to see priceInquiryInquiry
5mg98%$181.00Login to see priceInquiryInquiry
10mg98%$271.00Login to see priceInquiryInquiry
25mg98%$525.00Login to see priceInquiryInquiry
50mg98%$825.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFAA1 Agonist-1
IUPAC Name2-((4-((2'-chloro-[1,1'-biphenyl]-3-yl)methoxy)phenyl)sulfonyl)acetic acid
Molecular FormulaC21H17ClO5S
Molecular Weight416.88
SMILESO=C(O)CS(=O)(C1=CC=C(OCC2=CC(C3=CC=CC=C3Cl)=CC=C2)C=C1)=O
InChI KeyYEFZZALZTNOYEA-UHFFFAOYSA-N
Synonym2-[[4-[(2'-Chloro[1,1'-biphenyl]-3-yl)methoxy]phenyl]sulfonyl]acetic acid;FAA1 agonist-1;Acetic acid, 2-?[[4-?[(2'-?chloro[1,?1'-?biphenyl]?-?3-?yl)?methoxy]?phenyl]?sulfonyl]?-;GPR40 agonist 4;2-[[4-[(2'-Chloro[1,1'-biphenyl]-3-yl)methoxy]phenyl]sulfony...;GPR-40 agonist 4,GPR40 agonist 4;2-[4-({2'-chloro-[1,1'-biphenyl]-3-yl}methoxy)benzenesulfonyl]acetic acid
CAS No.2102196-57-4
PubChem CID131842087

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDPQY294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDPQY294 route product structure diagram
    ACDPQY2942102196-57-4
Inquiry

2. ACDPQY294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDPQY294 route product structure diagram
    ACDPQY2942102196-57-4
Inquiry

Comments (0)